Mochida Pharmaceutical Co.,Ltd.JP:4534Cash flow

Market cap
¥131.5B
P/E ratio
23.7x
2015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Depreciation & amortization3,0062,7642,7342,6182,9172,7312,7422,6892,6722,8082,940
Cash from operations 5,12215,2115,5833,28312,5659,3479,1987,4597,297-7,4809,354
Capital expenditures-1,930-1,827-1,106-1,095-1,368-1,958-1,935-2,988-2,166-2,296-2,160
Cash from investing -1,953-15,576-1,835-426-1,121-1,760-880-2,007-2,9497417,355
Payments for dividends -3,359-2,826-2,726-3,422-3,525-3,338-3,103-3,445-3,372-2,887-2,835
Repurchases of common stock-1,500-33-16-15-2,523-1,990-2,008-2,511-3,512-3,492-3
Repayments of term debt-375----------
Cash from financing -5,288-2,917-3,291-3,483-6,094-5,328-5,112-5,956-6,884-6,393-2,865